No Data
Hang Seng Index: Benefiting from policy support, biotechnology stocks have seen three consecutive months of inflows.
The Hang Seng Index company stated that there are signs of improvement in the recent situation of biotechnology stocks, as well as benefitting from policy support and three consecutive months of inflow of funds.
Tengshengbo Medicine -B (02137.HK) plans to hold a board of directors meeting on August 19 to approve its interim performance.
Tengshengbo Medicine-B (02137.HK) announced that the board of directors will hold a meeting on August 19, 2024 (Monday) to review and approve the unaudited interim performance of the company and its subsidiaries for the six months ended on June 30, 2024 and its publication, as well as to deal with other matters.
Brii Biosciences Says Unaffected by VBI Vaccines' Restructuring Under Creditors Arrangement Act, Shares Up 3%
Robert Taylor Nelsen resigned as non-executive director of Tengshengbo Medicine B (02137).
Tengshengbo Medicine-B (02137) released an announcement, Mr. Robert Taylor Nelsen...
Brii Biosciences Presents Hepatitis B Drug Data at European Medical Conference
Express News | Brii Bio Presents New Data From Its Ongoing Phase 2 Chronic Hepatitis B Trials at Easl™ Congress 2024
No Data
